Intra-Lock Dental Inc. – Trademark Portfolio
Entity Type: 03
Intra-Lock Dental Inc. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 11 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 14 trademarks are registered and 1 is pending. Notable registered marks include ORADAPT, X HINGE, CYTO-PRF, MUCOFLEX, and OMNIPLUG. The owner is based in Scottsdale, AZ.
8776 E Shea Blvd, Ste 106 PMB 144
Scottsdale, AZ 85260
Showing of trademarks Trademarks
Trademark Classifications
Intra-Lock Dental Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Intra-Lock Dental Inc. have?
Intra-Lock Dental Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 14 registered, 1 pending, 2 abandoned.
What trademark classes does Intra-Lock Dental Inc. file in?
Intra-Lock Dental Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Intra-Lock Dental Inc.'s most well-known trademarks?
Intra-Lock Dental Inc.'s registered trademark portfolio includes well-known marks such as ORADAPT, X HINGE, CYTO-PRF, MUCOFLEX, and OMNIPLUG. These are among 14 currently registered trademarks in the portfolio.
What is Intra-Lock Dental Inc.'s trademark registration success rate?
Intra-Lock Dental Inc. has a 88% trademark registration rate, with 14 out of 16 resolved applications resulting in successful registration. Currently, 1 application is pending review.